BRN Discussion Ongoing

IloveLamp

Top 20
View attachment 52004
"Huge array of new applications "

Screenshot_20231214_123612_Chrome.jpg
 
Last edited:
  • Like
  • Love
  • Fire
Reactions: 17 users

Bravo

If ARM was an arm, BRN would be its biceps💪!


Published 10 hours ago.

In this episode Xan Fredericks is joined by Josh Nimetz and Cindy Thatcher to continue the conversation about what's new and now in the realm of remote sensing specifically LiDAR. This discussion includes data suitability, increased efficiencies, considerations for accuracy, topographic lidar, bathymetric and top integrations, accuracy in integrated datasets, and what's next.
 
  • Like
  • Fire
Reactions: 4 users

IloveLamp

Top 20
  • Like
  • Fire
Reactions: 10 users

Bravo

If ARM was an arm, BRN would be its biceps💪!
  • Like
  • Fire
  • Love
Reactions: 21 users

Bravo

If ARM was an arm, BRN would be its biceps💪!
Here's a couple of extracts from an older article discussing Mobileye and Valeo's partnership to deliver best in class software defined radars. The radar technology has to be coupled with the sensors for it all to work.

Which IMO means coupling with Scala 3 lidar (AKIDA inside)


Screen Shot 2023-12-14 at 2.08.36 pm.png






Screen Shot 2023-12-14 at 1.57.12 pm.png


 
  • Like
  • Fire
  • Love
Reactions: 19 users

buena suerte :-)

BOB Bank of Brainchip
  • Like
  • Love
  • Haha
Reactions: 38 users

Bravo

If ARM was an arm, BRN would be its biceps💪!
Wonder if we're involved in this in some way given the project is sponsored by AFRL. Detect and avoid system that leverages radar and sensor fusion which is right down our alley.


Vigilant Aerospace secures military contract to develop detect-and-avoid system

November 8, 2023 - By Jesse Khalil
clock.png

Est. reading time: 1 minute
Image: Vigilant Aerospace

Vigilant Aerospace Systems, a provider of multi-sensor detect-and-avoid safety systems for UAVs and advanced air mobility (AAM), has been awarded a contract by the U.S. Air Force to develop a detect-and-avoid system for the Air Force’s new long-endurance UAV.
According to the published project description, the objective is to “integrate a mature detect and avoid capability on an existing long-endurance, Group V UAS platform, for increased aircraft and pilot-in-the-loop operational awareness that leverages new and evolving C-SWaP sensors and sensor fusion software.”
The project is sponsored by the Air Force Research Lab (AFRL) and is a Small Business Innovation Research (SBIR) Phase II project through the SBIR program. The program is designed to bring dual-use technologies, which can help both civilian and military users, into the military, with a focus on high-impact, near-term implementations.
FlightHorizon is detect-and-avoid and airspace management software that combines data from aircraft transponders, radar, UAV autopilots and live Federal Aviation Administration (FAA) data to create a single picture of the airspace around a UAV. The software displays air traffic, predicts trajectories and provides avoidance commands to the remote pilot or autopilot. The system can be used on the ground or onboard the UAV and can be configured for any size of aircraft.

The software is based on two licensed NASA patents and the company has completed contracts with NASA, the FAA and a project with the USAF’s 49th Operating Group’s MQ-9 Reaper fleet to track training flights. It is designed to meet industry technical standards and to help UAS operators fly beyond visual line-of-sight (BVLOS).
The new Air Force project incorporates prior research and development by the company in solving the automatic self-separation and collision avoidance problem for UAVs. To evaluate sensors and algorithms and establish standards-compliance and risk ratios, the company has completed hundreds of hours of flight tests with the system and thousands of simulated aircraft encounters inside the software’s built-in simulation engine, according to Vigilant Aerospace Systems.

Screen Shot 2023-10-15 at 10.43.39 am (1).png
 
  • Like
  • Fire
  • Wow
Reactions: 10 users

Terroni2105

Founding Member
Please bring Rob back for the interviews… Nandan is painful. Talks in circles, condescending tone and highlights limitations. Couldn’t even listen to end.
I disagree. I thought Nandan answered appropriately to the questions that were asked of him. And Sally let him talk freely because he was giving a lot of information and insights, it is clear he is a very knowledgeable fellow. I guess it depends on the audience listener as I like the way he explains things.
 
  • Like
  • Love
  • Fire
Reactions: 38 users

TECH

Regular
What if Dr T Lewis's appointment as CTO was not only to replace Peter in his semi retirement phase, but to further advance the development of BRN's Akida's "Cortical Columns" reseach and product range which has been worked on by Peter for some considerable time now ............ especially given imo the fact that Akida 2 (E, S & P) has already been launched and the Akida 3.0 is in it's final count down mode so imo there's probably very little involvement that will be or would be required from Dr T Lewis at this stage .. IMO, Dr T Lewis would have required some rather substantial technologically advanced development to lure him away from his last highly held position..... Accordingly, I believe that Dr T Lewis and Peter have their eye's well and truely set on the next biggest technological change and that being the further creation, refinement and deployment of Peter's own Brainchip Cortical Columns techology.

That's one of your better posts......you are right on the money in my view Xray1, I know for a fact that Peter not only chose Tony, has done some
work alongside him, and spoke in glowing terms of how Alan Harvey (SAB Perth) is doing some great work on Cortical Columns.

Peter is a visionary, his work will continue, a lot in his own private time, I know that he's comfortable taking a step back, but the vision and the
never give up attitude is still strong....the dream is still alive, and so should it be !!

CES will prove to be exciting for Brainchip, has anybody ever checked out Nextchip Co Ltd out of South Korea ?

💞 Brainchip.....Tech
 
  • Like
  • Love
  • Fire
Reactions: 29 users
That's one of your better posts......you are right on the money in my view Xray1, I know for a fact that Peter not only chose Tony, has done some
work alongside him, and spoke in glowing terms of how Alan Harvey (SAB Perth) is doing some great work on Cortical Columns.

Peter is a visionary, his work will continue, a lot in his own private time, I know that he's comfortable taking a step back, but the vision and the
never give up attitude is still strong....the dream is still alive, and so should it be !!

CES will prove to be exciting for Brainchip, has anybody ever checked out Nextchip Co Ltd out of South Korea ?

💞 Brainchip.....Tech
What made you bring them up TECH?


Just the kind of "dark horse" that BrainChip would suddenly partner with..

In answer to the question of our Korean connection/s..

"It's Samsung"
"It's Hyundai"
"It's LG"..

BrainChip Announces partnership/IP deal with Nextchip

"Nextchip?? Who the hell are they??"
 
  • Like
  • Haha
  • Fire
Reactions: 10 users

Tothemoon24

Top 20
IMG_7950.jpeg



The ⌚ Hyfe CoughMonitor ⌚ is an AI-powered wrist-wearable that monitors cough passively and in real-time. It runs the Hyfe CoughMonitor software, counting 90% of coughs with just 1 false positive per hour, whilst patients go about their normal daily activities.

The watch is slim, comfortable and light enough to be worn for days, weeks or even months at a time. It preserves privacy by processing entirely on device so no sound is uploaded to the cloud, whilst cough frequency data is visible immediately via a dashboard on the web. The CoughMonitor is being used by thousands of patients & researchers around the world.

For more information about how continuous cough-monitoring could help your research or clinical trials, schedule a 15 min call here:
 
  • Thinking
  • Like
  • Fire
Reactions: 10 users

Tothemoon24

Top 20
RELEASE
12 December 2023

New Hyfe AI Study Validates the Accuracy of AI-Powered Cough Detection Human Annotators​

6578abb0e787adda2fba983f_labeler%20intra%20inter%20agreement.png

Wilmington, Del., December 12, 2023 -- Hyfe, Inc., the global leader in AI-powered cough detection, tracking, and classification, today announces breakthrough results from a performance evaluation study comparing human cough annotators to emerging automated technologies using AI and machine learning. The BMJ Open Respiratory Research study demonstrates Hyfe’s cough detection AI technology is nearly as accurate as the human ear in analyzing the amount and duration of cough in a real-world environment.
The study analyzed 40 hours of audio randomly collected from participants wearing audio recording smartwatches throughout an average day. The audio samples were manually reviewed and annotated twice by one expert human annotator and some samples of the 40 hours were annotated a third time by six of Hyfe’s expert annotators. Key insights from the study include:
  • After evaluating several ways to track cough, researchers found that tracking cough by cough seconds, which are defined as any second of time that contains at least one cough, rather than counting individual coughs, decreased annotator discrepancy by 50 percent.
  • Compared to counting individual coughs, the study proposes that using cough rate over time is a more clinically relevant and reproducible performance metric for evaluating automatic systems.
  • Hyfe’s labeling software was reported by labelers to be easy to use, an improvement over Audacity, and likely to lead to fewer errors in data management.
  • The study provides guidance for researchers and developers working on these technologies and has the potential to lead to more reliable and consistent automatic cough monitoring tools.
Notably, the study is also the first to observe sex differences in cough, observing for the first time that the duration of cough sounds and epoch size differed between male and female participants. The study found that women tend to have shorter cough sounds but more coughs in each episode compared to men. These observed differences in cough characteristics could have important implications for the development of cough monitoring tools. They will be key in better understanding how diseases spread, diagnosing illnesses, and how people seek medical help.
“We’re thrilled that the results of this study confirm the accuracy of our robust automated cough monitoring technology,” said Joe Brew, CEO of Hyfe AI. “These findings pave the way for more accurate, reliable, and clinically relevant methods for cough tracking. They provide valuable insights that could significantly impact the much-needed development for monitoring coughs in healthcare and clinical trial settings. These are breakthrough discoveries in the chronic cough space and we look forward to taking an even deeper look into cough in future studies like this.”
Hyfe is the leader in longitudinal cough monitoring with over 700 million sounds in its cough database. It can track and detect cough with 90%+ accuracy on any mic-enabled device with no need for patient intervention while preserving patient privacy.

For more information, visit hyfe.ai.

About Hyfe
Hyfe, Inc. is the global leader in AI-powered cough detection and classification that provides insight into cough patterns and correlations and is being widely used to help patients gain a better understanding of their cough and have more informed conversations with their providers. With more than 700 million samples, Hyfe maintains the largest cough dataset in the world enabling the building of powerful models to track, manage and diagnose respiratory illnesses. Hyfe provides platforms and data for pharmaceutical companies, medical researchers, government agencies, health care providers and patients and has partnerships with leading academic institutions including Johns Hopkins University and the University of California at San Francisco. The company was founded in 2020 and is headquartered in Wilmington, Delaware. More information is available at Hyfe.ai, on social media @hyfeapp and LinkedIn at /hyfe.
 
  • Fire
  • Like
Reactions: 3 users
RELEASE
12 December 2023

New Hyfe AI Study Validates the Accuracy of AI-Powered Cough Detection Human Annotators​

6578abb0e787adda2fba983f_labeler%20intra%20inter%20agreement.png

Wilmington, Del., December 12, 2023 -- Hyfe, Inc., the global leader in AI-powered cough detection, tracking, and classification, today announces breakthrough results from a performance evaluation study comparing human cough annotators to emerging automated technologies using AI and machine learning. The BMJ Open Respiratory Research study demonstrates Hyfe’s cough detection AI technology is nearly as accurate as the human ear in analyzing the amount and duration of cough in a real-world environment.
The study analyzed 40 hours of audio randomly collected from participants wearing audio recording smartwatches throughout an average day. The audio samples were manually reviewed and annotated twice by one expert human annotator and some samples of the 40 hours were annotated a third time by six of Hyfe’s expert annotators. Key insights from the study include:
  • After evaluating several ways to track cough, researchers found that tracking cough by cough seconds, which are defined as any second of time that contains at least one cough, rather than counting individual coughs, decreased annotator discrepancy by 50 percent.
  • Compared to counting individual coughs, the study proposes that using cough rate over time is a more clinically relevant and reproducible performance metric for evaluating automatic systems.
  • Hyfe’s labeling software was reported by labelers to be easy to use, an improvement over Audacity, and likely to lead to fewer errors in data management.
  • The study provides guidance for researchers and developers working on these technologies and has the potential to lead to more reliable and consistent automatic cough monitoring tools.
Notably, the study is also the first to observe sex differences in cough, observing for the first time that the duration of cough sounds and epoch size differed between male and female participants. The study found that women tend to have shorter cough sounds but more coughs in each episode compared to men. These observed differences in cough characteristics could have important implications for the development of cough monitoring tools. They will be key in better understanding how diseases spread, diagnosing illnesses, and how people seek medical help.
“We’re thrilled that the results of this study confirm the accuracy of our robust automated cough monitoring technology,” said Joe Brew, CEO of Hyfe AI. “These findings pave the way for more accurate, reliable, and clinically relevant methods for cough tracking. They provide valuable insights that could significantly impact the much-needed development for monitoring coughs in healthcare and clinical trial settings. These are breakthrough discoveries in the chronic cough space and we look forward to taking an even deeper look into cough in future studies like this.”
Hyfe is the leader in longitudinal cough monitoring with over 700 million sounds in its cough database. It can track and detect cough with 90%+ accuracy on any mic-enabled device with no need for patient intervention while preserving patient privacy.

For more information, visit hyfe.ai.

About Hyfe
Hyfe, Inc. is the global leader in AI-powered cough detection and classification that provides insight into cough patterns and correlations and is being widely used to help patients gain a better understanding of their cough and have more informed conversations with their providers. With more than 700 million samples, Hyfe maintains the largest cough dataset in the world enabling the building of powerful models to track, manage and diagnose respiratory illnesses. Hyfe provides platforms and data for pharmaceutical companies, medical researchers, government agencies, health care providers and patients and has partnerships with leading academic institutions including Johns Hopkins University and the University of California at San Francisco. The company was founded in 2020 and is headquartered in Wilmington, Delaware. More information is available at Hyfe.ai, on social media @hyfeapp and LinkedIn at /hyfe.
I must be missing something here..

Am I now in an alternate reality, where people don't know whether they are coughing or not 🤔..
 
  • Haha
  • Like
  • Thinking
Reactions: 7 users

Diogenese

Top 20
I must be missing something here..

Am I now in an alternate reality, where people don't know whether they are coughing or not 🤔..
If I'm all alone in forest ... and a tree falls on me ...
 
  • Haha
  • Like
Reactions: 16 users

IloveLamp

Top 20
  • Like
  • Love
  • Fire
Reactions: 13 users

IloveLamp

Top 20
Screenshot_20231214_220841_LinkedIn.jpg
 
  • Like
  • Fire
Reactions: 11 users

IloveLamp

Top 20
  • Like
  • Love
  • Fire
Reactions: 6 users

IloveLamp

Top 20



Screenshot_20231214_221712_LinkedIn.jpg
 
  • Like
  • Fire
  • Love
Reactions: 13 users
Top Bottom